FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Orphenadrine citrate from Actavis Pharma, Inc., resulting in regulatory action on the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Disorders
• Musculoskeletal Pain

Drugs mentioned

• Orphenadrine citrate (Orphenadrine citrate)

Snippet

SUPPL AP for ORPHENADRINE CITRATE (ORPHENADRINE CITRATE)